Both in Pharmaceuticals
Xenetic Biosciences vs Alaunos Therapeutics
Over the past year XBIO returned −37.7% and TCRT returned −27.2%; their daily moves had a correlation of 0.07.
XBIO −37.7% TCRT −27.2%Growth of $1, one year, split-adjusted
| Metric | XBIO | TCRT |
|---|---|---|
| Price | $2.05 | $1.95 |
| Market cap | $4.8M | $5.0M |
| Today | −3.30% | +3.17% |
| 1 month | −8.5% | +112.0% |
| 6 months | −31.0% | −25.3% |
| Year to date | −5.5% | −39.6% |
| 1 year | −40.1% | −28.3% |
| Revenue growth (YoY) | +12.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −140.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.3× | 1,651.3× |
| Net cash | $6.5M | $124.0K |
| Dividend yield | — | — |
| Volatility (60d) | 160.4% | 272.0% |
| Short % of float | 0.5% | 30.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).